We provide you with 20 years of free, institutional-grade data for INDP stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of INDP. Explore the full financial landscape of INDP stock.
| Reported Date | CIK | Ticker | Type |
|---|
Indaptus Therapeutics, Inc.(NASDAQ:INDP) 
Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy. It engages in developing a pre-clinical pipeline of therapeutic candidates intended to elicit anti-tumor and anti-viral responses, as well as cure diseases. The company's l...
Share this website to your friends
The information provided in this report about INDP stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.